United States· US:63323-201_d19c26f4-1214-40f7-9680-43c885613306

Lidocaine

A medicinal product containing lidocaine hydrochloride, registered in United States by Fresenius Kabi USA, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLidocaineATC—REGISTER NO.US:63323-201_d19c26f4…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LIDOCAINE HYDROCHLORIDE
Manufacturer
Fresenius Kabi USA, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    63323-201-02
  • ndc11
    63323-201-10
  • ndc11
    6332320102
    25 VIAL in 1 TRAY (63323-201-02) / 2 mL in 1 VIAL (63323-201-01)
  • ndc11
    6332320110
    25 VIAL in 1 TRAY (63323-201-10) / 10 mL in 1 VIAL (63323-201-03)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lidocaine hydrochloride in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Cathejell, Dynexan
  • Belgium · Instillido, Lidocaine Aguettant
  • Bulgaria · Instillido, Lidocaine Hydrochloride Monohydrate Чайкафарма
  • Cyprus · Lidocaine Apta, Lidocaine Hydrochloride Noridem
  • Czechia · Lidocain Egis, Lidocaine Egis
  • Germany · Acoin, Actilogic
  • Denmark · Instillido, Lidbree
  • Estonia · Instillido, Lidocaine Accord
  • Spain · Actilogic, Dermovagisil
  • Finland · Esliva, Instillido
  • France · Chlorhydrate De Lidocaine Renaudin, Dynexan
  • United Kingdom (Northern Ireland) · Boots Severe Sore Throat Relief, Chloradirect Severe Sore Throat Relief
  • Greece · Carmelido, Consolid
  • Croatia · Dolokain, Instillido
  • Hungary · Lidocain Egis, Lidocain-Egis
  • Ireland · Dolocopin, Lidocaine Hydrochloride
  • Iceland · Lidocaine Grindeks, Lidokain Viatris
  • Italy · Asensil, Basicaina
  • Liechtenstein · Lidocain Walter Ritter
  • Lithuania · Instillido, Lidocain-Egis
  • Luxembourg · Dynexan Gel, Lidocain Braun
  • Latvia · Lidocaine Baxter, Lidocaine Egis
  • Malta · Lidocaine Hydrochloride Bp B. Braun Melsungen, Lidonostrum
  • Netherlands · Dynexan Mondgel, Instillido
  • Norway · Instillido, Lidocaine Accord
  • Poland · Bobodent, Bravera Control
  • Portugal · Lambdalina, Lidbree
  • Romania · Instillido, Lidocain
  • Sweden · Instillagel, Instillido
  • Slovenia · Instillido, Lidokain Kabi
  • Slovakia · Lidocain Egis, Lidocaine Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf9e3808-451d-416e-942d-bda3373a5e72
GET /v1/drugs/cf9e3808-451d-416e-942d-bda3373a5e72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INFILTRATION; PERINEURAL",
  "source": "ndc",
  "strength": "10",
  "substance": "LIDOCAINE HYDROCHLORIDE",
  "productndc": "63323-201",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA088586",
  "marketing_category": "ANDA"
}

See everything about lidocaine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.